Chlormezanone - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlormezanone and what is the scope of patent protection?
Chlormezanone
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for chlormezanone.
Summary for chlormezanone
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,712 |
| DailyMed Link: | chlormezanone at DailyMed |
Recent Clinical Trials for chlormezanone
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Canadian Institutes of Health Research (CIHR) | |
| Canadian Network for Observational Drug Effect Studies, CNODES | |
| Drug Safety and Effectiveness Network, Canada |
Medical Subject Heading (MeSH) Categories for chlormezanone
Anatomical Therapeutic Chemical (ATC) Classes for chlormezanone
US Patents and Regulatory Information for chlormezanone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | TRANCOPAL | chlormezanone | TABLET;ORAL | 011467-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | TRANCOPAL | chlormezanone | TABLET;ORAL | 011467-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
